Trevi Therapeutics Inc
TRVI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.01B
Close$
$0.13
99.1% downside
Current Fair Value
99.1% downsideOvervalued by 99.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.01 Billion |
|---|---|
| Enterprise Value | $1.99 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 1.08 |
| Outstanding Shares | 145,592,901 |
Return
| Return on Equity | -26.50% |
|---|---|
| Return on Assets | -25.40% |
| Return on Invested Capital | -30.63% |
Valuation & Multiples
| P/E Ratio | -45.14 |
|---|---|
| PEG | -163.64 |
| Price to Sales | - |
| Price to Book Ratio | 13.45 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -37.64 |
| Enterprise Value to Net Income | -44 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.3157▼ 85.64% |
|---|---|
| Total Calls | 923,100▲ 161.28% |
| Total Puts | 291,400▼ 29.63% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.73%▲ 2.91% |
|---|---|
| Total Invested | $1.61B▼ 1.04% |
| Investors Holding | 205▲ 13.00% |
ESG Score
No data